Clinical Trials Sponsored by Michael J. Fox Foundation for Parkinson's Research

Total 149 results

Michael J. Fox Foundation for Parkinson's Research

Active, not recruiting

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

Parkinson Disease

United States
Michael J. Fox Foundation for Parkinson's Research

Recruiting

Parkinson Progression Marker Initiative Online (PPMI Online)

Parkinson Disease

United States
Michael J. Fox Foundation for Parkinson's Research
Sanofi

Terminated

A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease

Parkinson's Disease

United States
Takeda
Michael J. Fox Foundation for Parkinson's Research

Completed

A Study of TAK-071 in People With Parkinson Disease

Parkinson Disease | Healthy Participants

United States
Norconnect Inc
Michael J. Fox Foundation for Parkinson's Research

Completed

Electromyography Signals as Biomarkers for Parkinson's Disease

Parkinson's Disease

United States
Allyx Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Recruiting

A Study to Assess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson's

Parkinson Disease

United States
Yale University
Fox (Michael J.) Foundation for Parkinson's Research

Recruiting

Ketamine for the Treatment of Depression in Parkinson's Disease (KET-PD)

Depression | Parkinson's Disease

United States
Avanir Pharmaceuticals
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients (LID in PD)

Parkinson's Disease | Dyskinesia

Canada, United States
Acorda Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Idiopathic Parkinson's Disease

Israel, Serbia, United Kingdom
Bastyr University
Michael J. Fox Foundation for Parkinson's Research

Completed

Phase IIb Study of Intranasal Glutathione in Parkinson's Disease ((in)GSH)

Parkinson's Disease

United States
NeuroDerm Ltd.
Michael J. Fox Foundation for Parkinson's Research

Completed

A Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients

Parkinson's Disease

Israel
Allyx Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Active, not recruiting

Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers

Dementia | Alzheimer Disease

United States
Alkahest, Inc.
Michael J. Fox Foundation for Parkinson's Research

Completed

A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

Parkinson Disease

United States, France, Australia
Columbia University
Michael J. Fox Foundation for Parkinson's Research

Completed

Antigen Presentation and Lymphocyte Response in Parkinson's Disease

Parkinson's Disease

United States
Emory University
Michael J. Fox Foundation for Parkinson's Research

Completed

Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes

Parkinson's Disease

United States
Indiana University
Michael J. Fox Foundation for Parkinson's Research

Completed

PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2) (PROGENI)

Parkinson Disease

United States, Canada
Michael J. Fox Foundation for Parkinson's Research
Institute for Neurodegenerative Disorders

Recruiting

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort (PPMI)

Parkinson Disease

United States, Canada, Spain, Israel, Austria, Germany, Greece, Italy, Netherlands, Nigeria, United Kingdom, Luxembourg
Michael J. Fox Foundation for Parkinson's Research
Institute for Neurodegenerative Disorders

Completed

PPMI Tau PET Imaging

Parkinson Disease

United States
Xuanwu Hospital, Beijing
Michael J. Fox Foundation for Parkinson's Research

Completed

LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers

Parkinson Disease

China
University of Chicago
Michael J. Fox Foundation for Parkinson's Research

Completed

Long-term Effect of Low Frequency Stimulation on Aspiration and Freezing of Gait in PD With STN DBS

Parkinson's Disease

United States
Motus Therapeutics, Inc.
Michael J. Fox Foundation for Parkinson's Research

Terminated

A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation (MOVE-PD)

Parkinson's Disease

United States
NeuroHealing Pharmaceuticals Inc.
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients (NH004-2)

Sialorrhea Secondary to Parkinson's Disease

Argentina
Molecular Biometrics, Inc.
Michael J. Fox Foundation for Parkinson's Research

Unknown

Spectroscopy in Parkinson Disease (SPIN-PD)

Parkinson Disease

United States
Virginia Commonwealth University
Michael J. Fox Foundation for Parkinson's Research

Completed

Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease

Parkinson Disease

United States
The Cleveland Clinic
Michael J. Fox Foundation for Parkinson's Research

Completed

Dual-task Augmented Reality Treatment for Parkinson's Disease (DART)

Parkinson Disease

United States
Virginia Commonwealth University
Michael J. Fox Foundation for Parkinson's Research

Withdrawn

Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease

Parkinson Disease

United States
University Hospital Tuebingen
Michael J. Fox Foundation for Parkinson's Research

Unknown

Combined Stimulation of STN and SNr for Dysphagia in Parkinson's Disease

Parkinson's Disease | Dysphagia

Germany
NeuroHealing Pharmaceuticals Inc.
Michael J. Fox Foundation for Parkinson's Research

Completed

Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients

Sialorrhea (Excessive Drooling)

France
University of Pennsylvania
Michael J. Fox Foundation for Parkinson's Research

Completed

Naltrexone for Impulse Control Disorders in Parkinson's Disease

Parkinson Disease | Impulse Control Disorder

United States
University of Cincinnati
Michael J. Fox Foundation for Parkinson's Research

Completed

Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease

Parkinson's Disease | Gait Impairment

United States
Salena Killion
Michael J. Fox Foundation for Parkinson's Research

Unknown

Using Heavy Water to Study Cell Dynamics in Parkinson's Disease

HIV Infections | Parkinson's Disease

United States
University of Toronto
Michael J. Fox Foundation for Parkinson's Research

Unknown

L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

Parkinson's Disease

Canada
University of Michigan
Michael J. Fox Foundation for Parkinson's Research

Completed

Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson's Disease

Parkinson's Disease

United States
The Cleveland Clinic
Michael J. Fox Foundation for Parkinson's Research

Recruiting

Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming

Parkinson Disease | Virtual Reality | Freezing of Gait | Deep Brain Stimulation | DBS

United States
University of Iowa
Michael J. Fox Foundation for Parkinson's Research

Active, not recruiting

Target Engagement of Terazosin in Healthy Adults

Healthy

United States
Spaulding Rehabilitation Hospital
Michael J. Fox Foundation for Parkinson's Research

Terminated

EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease

Parkinson

United States
NYU Langone Health
Michael J. Fox Foundation for Parkinson's Research

Completed

Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease

Parkinson Disease | Multiple System Atrophy | REM Sleep Behavior Disorder | Pure Autonomic Failure | Dementia With Lewy Bodies

United States
University of Washington
Michael J. Fox Foundation for Parkinson's Research

Unknown

Measures of Mitochondria Dysfunction in PD

Parkinson Disease, Mitochondrial

United States
University of Rochester
Michael J. Fox Foundation for Parkinson's Research

Completed

Buspirone in Parkinson's Disease

Parkinson Disease | Anxiety

United States
Impax Laboratories, LLC
Michael J. Fox Foundation for Parkinson's Research

Completed

Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study

Parkinson's Disease

United States
University of Pennsylvania
Michael J. Fox Foundation for Parkinson's Research

Completed

Biomarkers in Neural Disorders

Parkinson's Disease | Myasthenia Gravis | Spinal Cord Injuries | Multiple System Atrophy | Progressive Supranuclear Palsy | Essential Tremor | Alzheimer's Disease | Diffuse Lewy Body Disease | Drug Induced Parkinson's Disease

United States
University of Michigan
Michael J. Fox Foundation for Parkinson's Research

Completed

Cholinergic Nicotinic Receptors and Cognition in PD (CHONI)

Parkinson's Disease

United States
Virginia Commonwealth University
Michael J. Fox Foundation for Parkinson's Research

Completed

A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease

Parkinson's Disease | Mild Cognitive Impairment

United States
University of Washington
Michael J. Fox Foundation for Parkinson's Research

Completed

CNS Uptake of Intranasal Glutathione

Parkinson's Disease

United States
University of Florida
Michael J. Fox Foundation for Parkinson's Research

Completed

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's Disease (ReStore)

Parkinson's Disease

United States
23andMe, Inc.
Michael J. Fox Foundation for Parkinson's Research; The Parkinson's Institute

Completed

Web-based Genetic Research on Parkinson's Disease

Parkinson's Disease

United States
Michael Alan Schwarzschild
Michael J. Fox Foundation for Parkinson's Research; The Parkinson Alliance

Completed

A Food-Drug Interaction Study of Serum Urate After Oral Inosine

Healthy

United States
Radboud University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

PERsonalized SPEeCh Therapy for actIVE Conversation (PERSPECTIVE)

Parkinson Disease

Netherlands
University of Colorado, Denver
Michael J. Fox Foundation for Parkinson's Research

Completed

Acupuncture for Fatigue in Parkinson's Disease

Parkinsons Disease

United States
Rush University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Terminated

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease (TOP-DYSK)

Idiopathic Parkinson's Disease | Drug Induced Dyskinesia

United States

Clinical Trials Sponsored by Michael J. Fox Foundation for Parkinson's Research

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations